Pierre Fabre and Lonza Enter Manufacturing Agreement for W0180 Antibody Drug Product
Lonza will provide clinical drug product manufacturing for W0180, an oncology drug candidate discovered by Pierre Fabre targeting solid tumors,
Read MoreLonza will provide clinical drug product manufacturing for W0180, an oncology drug candidate discovered by Pierre Fabre targeting solid tumors,
Read More